SREBF1 and fatty liver disease: Emodin (9) can improve hepatic steatosis in rats with liquid fructose-induced NAFLD by inhibiting the adipogenic transcription factor SREBP-1c and its downstream proteins FAS and stearoyl coenzyme A desaturase 1 (SCD1) (Li et al., 2016).